These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6201838)

  • 1. [Inhibition of anti-IgE-stimulated histamine liberation from sensitized leukocytes of patients with allergic bronchial asthma treated with theophylline].
    Morr H; Heinlein P
    Prax Klin Pneumol; 1984 Apr; 38(4):129-31. PubMed ID: 6201838
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro influence of theophylline on anti-IgE-induced release from leucocytes and whole blood in asthmatic children.
    Scheinmann P; Burtin C; Paupe H; Lebel B; Fermanian J
    Agents Actions; 1981 Apr; 11(1-2):109-10. PubMed ID: 6166162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The in-vitro histamine liberation in human leukocytes sensitized by grass pollen. Pharmacological application of the study on racephedrine and theophylline (proceedings)].
    Biot N; Kofman J; Grosclaude M; Perrin-Fayolle M
    Acta Allergol; 1977 Jun; 32(3):221-2. PubMed ID: 70946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of protein kinase on histamine release from human leukocytes by anit-IgE (author's transl)].
    Kurosawa M; Nemoto T; Tanaka T; Fueki R; Kobayashi S; Nagai H; Koda A
    Arerugi; 1981 Jun; 30(6):308-15. PubMed ID: 6177302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypersensitivity of the leukocytes in children with bronchial asthma. 2. Fluctuation of histamine liberation reaction of leukocytes during desensitization].
    Tomita A
    Nihon Shonika Gakkai Zasshi; 1971 Nov; 75(11):1017-21. PubMed ID: 4112291
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitory action amlexanox on interleukin-3-induced enhancement of histamine releasability of human leukocytes].
    Urisu A; Iimi K; Kondo Y; Horiba F; Masuda S; Tsuruta M; Yazaki T; Torii S
    Arerugi; 1990 Oct; 39(10):1448-54. PubMed ID: 1701989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukocyte sensitivity in bronchial asthma in children. 1. Histamine liberation of leukocytes in bronchial asthma in children].
    Tomita A
    Nihon Shonika Gakkai Zasshi; 1970 Oct; 74(10):894-9. PubMed ID: 4097802
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of IgE-mediated histamine release from human leukocytes by a new xanthine derivative, D 4026.
    Petersson BA; Svedinger I; Bohlinder K
    Agents Actions; 1980 Nov; 10(5):403-10. PubMed ID: 6163338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased release of histamine by anti-IgE from leucocytes of asthmatic patients and possible heterogeneity of IgE.
    Assem ES; Attallah NA
    Clin Allergy; 1981 Jul; 11(4):367-74. PubMed ID: 6170475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug, HC 20-511 (ketotifen).
    Tomioka H; Yoshida S; Tanaka M; Kumagai A
    Monogr Allergy; 1979; 14():313-7. PubMed ID: 91958
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toluene-diisocyanate-induced asthma. 2. Histamine liberation test using leukocytes from toluene-diisocyanate sensitized guinea pigs].
    Kido T; Yamada Y; Teranishi H
    Arerugi; 1983 Mar; 32(3):131-7. PubMed ID: 6194773
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
    J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchial asthma and anti-allergic agents].
    Tomioka H
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1448-54. PubMed ID: 1280670
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on "late onset" asthma. 1. Anti-IgE induced release of histamine from whole blood].
    Tanizaki Y; Komagoe H; Sudo M; Nakayama K; Goda Y; Tada S; Takahashi K; Kimura I
    Arerugi; 1983 Nov; 32(11):1093-8. PubMed ID: 6203504
    [No Abstract]   [Full Text] [Related]  

  • 16. IgE mediated histamine release: in vitro separation into two phases.
    Lichtenstein LM; De Bernardo R
    Int Arch Allergy Appl Immunol; 1971; 41(1):56-71. PubMed ID: 4104671
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cyclic AMP in inhibiting the IgE-mediated release of histamine.
    Lichtenstein LM
    Ann N Y Acad Sci; 1971 Dec; 185():403-12. PubMed ID: 4107676
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine release from human leukocytes: modulation by a cytochalasin B-sensitive barrier.
    Colten HR; Gabbay KH
    J Clin Invest; 1972 Jul; 51(7):1927-31. PubMed ID: 4113392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
    Kivity S; Onn A; Agami O; Fireman E
    Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T; From S
    Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.